http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HK-1128622-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2292
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 2009-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_418d93662e0dacc43f59eb4fd8fda6f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32d2011d9cf4d8aa7cb807ffae7c7505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a5233fb608b21fc67b88e401c641d12
publicationDate 2009-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HK-1128622-A1
titleOfInvention Use of thymosin
abstract It is described the use of thymosin alpha 1 in combination with long pentraxin PTX3 or Ganciclovir, for the preparation of a medicament for the prevention or treatment of viral diseases and/or for inhibiting virus activation.
priorityDate 2006-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503830

Total number of triples: 22.